Drugs / CHG
last change Jun 2022 re-read 2 minutes ago

CHG

Developed for
COVID-19
Investigated by
University of Wisconsin, Madison

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT04478019 Jul 2020 → Jun 2022 COVID-19 University of Wisconsin, Madison Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CHG ClinicalTrials.gov intervention name — accepted as the source's own label NCT04478019
Route Oral “0.12% CHG oral rinse” NCT04478019